Fierce Biotech: Trialbee adds ex-Lundbeck CEO, Bristol-Myers exec to board

Social_1200x630_Adds new board members

Fierce Biotech: Trialbee adds ex-Lundbeck CEO, Bristol-Myers exec to board

Trialbee has added a pair of biopharma heavyweights to its board of directors. Read more in this article from Fierce Biotech.

For more information, request a demo of this solution.

}

August 26, 2016

m

News

← PREVIOUS NEXT →

RECENT POSTS

Trialbee Partners with Savvy Cooperative to Bring the Voice of the Patient into Clinical Trials Earlier

Trialbee Partners with Savvy Cooperative to Bring the Voice of the Patient into Clinical Trials Earlier

Powerful collaboration provides a forum for...

5 Ways to Prepare Your Clinical Trials for Diversity in 2023 and Beyond

5 Ways to Prepare Your Clinical Trials for Diversity in 2023 and Beyond

It seems like we're finally about to see a...

Trialbee to Showcase How Customers Use the Trialbee Honey™ Platform to Take Control of Global Patient Recruitment at SCOPE Summit 2023 (Feb 6-9, Orlando, FL)

Trialbee to Showcase How Customers Use the Trialbee Honey™ Platform to Take Control of Global Patient Recruitment at SCOPE Summit 2023 (Feb 6-9, Orlando, FL)

CEO Matt Walz to join investment panel and chair...

Acclinate and Trialbee | 5 Key Trends: Are Your Clinical Trials Ready for Diversity in 2023?

Acclinate and Trialbee | 5 Key Trends: Are Your Clinical Trials Ready for Diversity in 2023?

Duration: 60 minutesSpeakers: Del Smith, PhD...

Acclinate and Trialbee | 5 Key Trends: Are Your Clinical Trials Ready for Diversity in 2023?

Trialbee and Acclinate to Host Informational Webinar on the 5 Key Trends Poised to Significantly Improve Clinical Trial Patient Diversity in 2023

On January 25, CEOs Matt Walz and Del Smith,...